Gynecologic Oncology | Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer

Research To Practice | Oncology Videos

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

5y ago 40:00

QUICKTIME•Episode home

Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Robert L Coleman, Prof Jonathan A Ledermann, Dr Stephanie Lheureux and Dr Kathleen Moore:

Genomic Testing and Management of Primary Ovarian Cancer — Dr Moore (00:00)
Role of PARP Inhibition in the Management of Relapsed Ovarian Cancer — Prof Ledermann (10:37)
Prevention, Recognition and Management of PARP Inhibitor-Associated Side Effects — Dr Coleman (21:04)
Investigational Applications of Approved PARP Inhibitors; Other PARP Inhibitors in Clinical Development — Dr Lheureux (29:33)

Select publications

1327 episodes

#Science #Medicine #Cancer #Neillove #Oncology #Researchtopractice #Fitness #Dr Neil Love #Video